towardshealthcare

[towardshealthcare]

Endoscopy Devices Market Trends, Overview 2025

The global endoscopy devices market was valued at USD 61.1 billion in 2024, increased to USD 63.44 billion in 2025, and is expected to reach USD 88.55 billion by 2034, growing at a CAGR of 3.82%. Market growth is driven by the rising prevalence of chronic diseases and ongoing technological advancements, with strong regional and segment-specific trends shaping the future outlook.

Key Highlights

North America dominance (2024): The region accounted for the largest market share, supported by advanced healthcare infrastructure.

Asia-Pacific growth: Expected to be the fastest-growing region, driven by increasing healthcare investments and demand.

Endoscopes lead by product (2024): The endoscope segment held a dominant market position, highlighting its widespread usage.

Visualization systems growth: The endoscopy visualization systems segment is projected to see significant expansion, supported by technological innovations.

Outpatient facilities lead (2024): Outpatient facilities were the largest end-use segment, while hospitals are expected to show lucrative growth in the coming years.

[towardshealthcare]

Life Science Analytics Market Key Highlights 2025

The global life science analytics market was valued at USD 10.47 billion in 2024, increased to USD 11.27 billion in 2025, and is projected to reach USD 21.85 billion by 2034, growing at a CAGR of 7.63%. Market growth is driven by rising R&D activities and technological advancements, with strong adoption across pharma, biotech, and healthcare industries.

Key Highlights

North America dominance (2024): Led the market share, while Asia-Pacific is set to record the fastest growth.

Services segment leadership: Services held the largest share in 2024 and are expected to grow at the fastest pace.

Type trends: Descriptive analytics held the largest share in 2024, while predictive analytics is projected to grow at the highest CAGR.

Applications: Sales & marketing support dominated in 2024, whereas R&D analytics is expected to expand rapidly.

End-user outlook: Pharmaceutical companies led in 2024, while the biotechnology segment is forecast to grow the fastest.

[towardshealthcare]

Medical Device Testing Market Top Key Players 2025

The global medical device testing market, valued at USD 10.77 billion in 2025, is projected to grow to USD 24.32 billion by 2034, at a CAGR of 9.47%. Growth is driven by the rising demand for safe, reliable, and high-quality medical devices along with stringent global regulatory standards that require rigorous product testing and certification.

Top 5 Companies and Strengths

SGS SA – Strong global network with comprehensive testing, inspection, and certification services.

Laboratory Corporation of America Holdings (LabCorp) – Expertise in clinical laboratory services and advanced diagnostic testing.

Nelson Laboratories, LLC – Specialized in microbiological and analytical testing for medical devices.

TÜV SÜD – Recognized for regulatory compliance, certification, and safety testing across global markets.

Charles River Laboratories – Strength in preclinical and non-clinical testing with a focus on medical device safety and biocompatibility.

[towardshealthcare]

Rehabilitation Equipment Market Size, Trends 2025

Rehabilitation Equipment Market Overview The global rehabilitation equipment market was valued at USD 17 billion in 2024, grew to USD 18.42 billion in 2025, and is projected to reach USD 37.34 billion by 2034, expanding at a CAGR of 8.34%. Growth is driven by the rising prevalence of chronic disorders and rapid technological advancements, with North America holding the largest share while Asia-Pacific shows the fastest growth potential.

Key Highlights

43% market share in 2024 – North America dominated due to advanced healthcare infrastructure and high adoption of rehabilitation devices.

Asia-Pacific – fastest growth region during the forecast period, driven by increasing healthcare investments and rising patient pool.

Therapy equipment segment – leading in 2024, reflecting strong demand for advanced therapy solutions in rehabilitation.

Daily living aids – fastest growth segment, fueled by rising demand for home-based patient assistance equipment.

Hospitals & clinics held the largest share in 2024, while rehabilitation centers are projected to witness significant growth, supported by specialized care facilities.

[towardshealthcare]

 DNA Vaccine Market Top Companies 2025

The global DNA vaccine market was valued at US$ 553.89 million in 2024, grew to US$ 590 million in 2025, and is expected to reach US$ 1,041.68 million by 2034, expanding at a CAGR of 6.52%. Growth is driven by rising demand for advanced vaccines, increasing focus on infectious diseases and cancer, and benefits such as stability, safety, and rapid development.

1. Inovio Pharmaceuticals

Overview: U.S. biotech focused on DNA medicines.

Product: INO-4800 (COVID-19 DNA vaccine).

Strength: Room-temp stability, rapid design, broad pipeline.

2. AstraZeneca

Overview: Global pharma giant.

Product: Adenovirus-based COVID vaccine (Covishield).

Strength: Large-scale R&D, global manufacturing reach.

3. Pfizer

Overview: U.S. pharma leader.

Product: Comirnaty (mRNA, with BioNTech), DNA tech via PowderMed.

Strength: Strong infrastructure, wide vaccine portfolio.

4. BioNTech

Overview: German biotech, mRNA innovator.

Product: Comirnaty (with Pfizer).

Strength: Cutting-edge R&D, oncology pipeline, rapid adaptability.

5. Moderna

Overview: U.S. mRNA specialist.

Product: Spikevax (COVID), RSV, flu-COVID combo.

Strength: Fast R&D platform, scalable production, diverse pipeline.

[towardshealthcare]

Surgical Sutures Market Highlights and Overview 2025

The global surgical sutures market was valued at USD 4.84 billion in 2024 and is set to grow to USD 5.09 billion in 2025, reaching around USD 7.96 billion by 2034 at a steady CAGR of 5.14% (2025–2034). North America currently dominates with the largest share, while Asia Pacific is expected to witness the fastest growth. Absorbable sutures and multifilament types are leading segments, with cardiovascular and orthopedic surgeries driving demand.

Key Highlights

USD 7.96 billion by 2034 → Market expansion from USD 4.84 billion (2024) shows steady growth momentum.

North America: 45% share (2024) → Strong dominance due to advanced healthcare infrastructure.

Asia Pacific: fastest growth → Rising surgeries and healthcare investments fuel market acceleration.

Absorbable sutures: leading & fastest-growing type → Preferred for better healing and reduced complications.

Orthopedic surgery: fastest-growing application → Increasing bone and joint procedures boost demand.

[towardshealthcare]

Vaccines Market Insights 2025

The global vaccines market reached USD 81.67 billion in 2024 and is projected to grow to USD 121.36 billion by 2034, expanding at a CAGR of 4.04%. Growth is fueled by rising vaccination demand, government initiatives, and technological advancements like AI and genomics. North America leads the market, while Asia-Pacific is expected to grow the fastest.

Key Insights

📈 Market Size Growth – From USD 81.67 billion (2024) to USD 121.36 billion (2034), reflecting steady expansion.

🌍 Regional Trends – North America dominated in 2024, while Asia-Pacific is projected to record the fastest growth.

💉 Vaccine Type – Subunit/conjugate/recombinant protein vaccines led in 2024, but mRNA vaccines are expected to grow the fastest.

👶 Target Disease – Pediatric routine immunizations held the largest share in 2024, while seasonal respiratory vaccines are set to rise quickly.

🏭 Manufacturing Model – Commercial scale manufacturing dominated in 2024, but contract manufacturing will witness the highest CAGR.

[towardshealthcare]

Theranostics Market Size, Trends 2025

The global theranostics market, valued at USD 2.42 billion in 2024, is projected to reach USD 10.21 billion by 2034, growing at a strong CAGR of 15.46% (2025–2034). Rising cancer cases in the US, China, India, and Japan are fueling the demand for advanced diagnostic and therapeutic solutions. Radiopharmaceuticals, molecular imaging, and nanoparticle-based technologies are driving innovation, while oncology remains the leading application area. Hospitals & clinics dominate adoption, but diagnostic imaging centers are emerging as the fastest-growing end users.

Key Highlights

USD 10.21 billion by 2034 – Market projected to expand significantly from USD 2.42 billion in 2024, reflecting strong growth.

15.46% CAGR (2025–2034) – Driven by increasing cancer and neurological disease cases globally.

40% market share in North America (2024) – Region leads due to advanced healthcare infrastructure and adoption of theranostics.

Radiopharmaceuticals held 38% share in 2024 – Widely used for diagnostic and therapeutic purposes.

Oncology captured 27% share in 2024 – Expected to remain the largest and fastest-growing application segment.

[towardshealthcare]

Oxygen Concentrators Market Highlights and Overview

The global oxygen concentrators market is valued at US$ 1.14 billion in 2024 and is projected to reach US$ 2.05 billion by 2034, growing at a CAGR of 6.06%. Growth is driven by rising cases of chronic respiratory diseases, an aging population, and smoking-related disorders. North America currently dominates due to advanced technologies, while Asia Pacific is the fastest-growing region with expanding healthcare access.

Key Highlights

The oxygen concentrators market is valued at US$ 1.14 billion in 2024.

Market projected to reach US$ 2.05 billion by 2034.

Estimated to expand at a CAGR of 6.06% (2025–2034).

North America leads the market in 2024 due to advanced technologies.

Asia Pacific expected to be the fastest-growing region during the forecast period.

Stationary oxygen concentrators dominate revenue in 2024.

[towardshealthcare]

Monoclonal Antibodies Market Latest Trends 2025

The global monoclonal antibodies (mAbs) market was valued at USD 254.89 billion in 2024, expected to grow to USD 286.6 billion in 2025 and further reach USD 823.31 billion by 2034, at a CAGR of 12.44%. North America currently dominates, while Asia-Pacific is the fastest-growing region. Oncology leads in therapeutic applications, with ADCs and advanced bioprocessing platforms driving the next wave of growth. Increasing collaborations, funding, and AI-driven drug discovery are accelerating innovation in this sector.

Major Monoclonal Antibodies Market Trends

Rising Market Growth – Expanding from USD 254.89 billion (2024) to USD 823.31 billion (2034) at a CAGR of 12.44%, showing strong long-term demand.

Oncology Dominance – Cancer treatment remains the largest and fastest-growing segment, with continuous mAb innovation in immuno-oncology.

ADC & Bispecifics Expansion – Antibody-drug conjugates (ADCs) and bispecific antibodies are emerging as high-growth modalities, gaining strong clinical traction.

AI-Driven Drug Discovery – Artificial intelligence is increasingly adopted to reduce errors, accelerate R&D, and improve drug discovery platforms.

Collaborations & Funding Rounds – Strategic alliances and investments (e.g., USD 131M financing for Minghui Pharmaceutical) are boosting clinical programs and global commercialization.

[towardshealthcare]

Infectious Disease Diagnostics Market Key Insights 2025

The global infectious disease diagnostics market stood at USD 25.01 billion in 2024 and is projected to reach USD 62.95 billion by 2034, growing at a 9.67% CAGR. Growth is driven by rising infection rates, demand for rapid testing, and advancements in molecular and point-of-care diagnostics. North America currently leads the market, while Asia Pacific is set to witness the fastest growth.

Key Insights

Market Growth: Valued at USD 25.01 billion (2024), projected to reach USD 62.95 billion (2034) at 9.67% CAGR.

Regional Trends: North America led in 2024, while Asia Pacific is expected to grow at the fastest pace.

Product Segments: Reagents, kits & consumables dominated in 2024; instruments will see the fastest CAGR.

Technology Adoption: Immunodiagnostics led in 2024; molecular diagnostics to expand rapidly.

Testing Settings: Laboratory-based testing dominated in 2024, while point-of-care testing is expected to rise fastest.

[towardshealthcare]

Cardiac Safety Services Market Highlights and Growth Factor

The global cardiac safety services market was valued at USD 824.35 million in 2024, is expected to reach USD 919.57 million in 2025, and projected to hit USD 2,459.29 million by 2034 at a strong CAGR of 11.55%. North America led the market, while Asia-Pacific is anticipated to grow fastest. Growing cardiovascular disorders, advanced ECG monitoring, and increasing demand from pharma & CROs are fueling market expansion.

Key Highlights

Market Growth: Expanding from USD 824.35M (2024) to USD 2,459.29M (2034), growing at 11.55% CAGR.

Regional Share: North America dominated with 38% revenue share in 2024, while Asia-Pacific to record the fastest growth.

Service Insights: ECG/holter measurement & analysis held 30% share in 2024, while continuous ECG telemetry expected to surge ahead.

End User Trends: Pharma & biopharma firms led with 45% share, but CROs to grow quickest in the forecast period.

Drug Development & Therapeutic Area: Phase III trials dominated with 35% share, oncology led with 28% share, while phase II trials and cardiology to witness fastest rise.

[towardshealthcare]

AI in Telehealth & Telemedicine Market Growth and Overview 2025

The global AI in telehealth & telemedicine market was valued at US$ 3.89 billion in 2024, expected to reach US$ 5.3 billion in 2025, and projected to hit US$ 86.31 billion by 2034, expanding at a strong CAGR of 36.35%. Growth is driven by rising demand for remote healthcare, AI-powered diagnosis, real-time patient monitoring, and government-led telehealth programs worldwide.

Key Market Growth Drivers

Rising Remote Healthcare Demand – Increasing adoption of remote patient monitoring is fueling AI-enabled telehealth solutions.

Government Initiatives – Programs like India’s National Tele Mental Health Programme and Japan’s online medical consultation boost adoption.

AI-Powered Predictive Analytics – Machine learning identifies health risks early, reducing hospital stays and improving care.

Cloud-Based Platforms Expansion – Cloud AI telehealth solutions dominate deployment and ensure scalability with cost efficiency.

Asia-Pacific Growth Potential – Region expected to grow at the fastest CAGR due to expanding digital health infrastructure and government support.

[towardshealthcare]

Softgel Capsules Market Trends 2025

Overview

The global softgel capsules market was valued at USD 9.88 billion in 2024, rose to USD 10.47 billion in 2025, and is projected to reach USD 17.59 billion by 2034, growing at a CAGR of 5.94%. Rising demand for plant-based, clean-label products, innovations in personalized nutrition, and the adoption of advanced encapsulation technologies are fueling growth. Expansion into beauty-from-within supplements and adoption of smart manufacturing practices further drive market opportunities.

Market Trends in Softgel Capsules Market

Shift to Plant-Based Capsules → Consumers are moving from animal gelatin to HPMC, starch, and pullulan for vegan, halal, and kosher options.

Personalized Nutrition & Controlled Release → Custom formulations with sustained or enteric release are gaining demand for tailored health needs.

Expansion into Beauty & Cosmetics → Softgels with collagen, hyaluronic acid, and skin nutrients are rising for skincare and haircare.

Advanced Encapsulation for Bioavailability → Techniques like nano-encapsulation and lipid-based systems improve absorption and stability.

Sustainability & Smart Manufacturing → Use of AI-driven automation and eco-friendly materials ensures efficiency, reduced waste, and greener production.

[towardshealthcare]

Cell Culture Market Shares, Trends and Overview 2025

The global cell culture market reached USD 20.61 billion in 2024, is set to grow to USD 22.95 billion in 2025, and projected to hit USD 60.38 billion by 2034, expanding at a robust CAGR of 11.35% (2024–2034). North America currently leads the market, while Asia Pacific is anticipated to witness rapid growth. Rising demand for biopharmaceutical production and increasing use of consumables are driving market expansion, alongside strong opportunities in diagnostics and stem cell research.

Key Highlights

USD 60.38 Billion by 2034 – Market growth driven by biopharma demand and technological advancements.

North America leads in 2024 – Strong infrastructure and investments make it the largest regional market.

Asia Pacific high CAGR (2025–2034) – Growing biotech sector and healthcare investments boost adoption.

Consumables dominated in 2024 – Regular need for media, reagents, and supplies ensures steady revenue.

Stem cell culture media rising fast – Expected to record notable CAGR due to regenerative medicine focus.

[towardshealthcare]

Peptide Synthesis Market Size, Shares and Growth

The global peptide synthesis market was valued at USD 686.59 million in 2024 and is projected to grow to USD 2,277.59 million by 2034, expanding at a strong CAGR of 12.74% from 2025 to 2034. North America dominated in 2024, while Asia Pacific is expected to grow rapidly. The market is driven by rising demand in therapeutics, diagnostics, and biotechnology applications, with CDMOs/CROs emerging as a high-growth segment.

Key Highlights

Market Growth: From USD 686.59M (2024) to USD 2,277.59M (2034) at a 12.74% CAGR, indicating robust expansion.

Regional Insights: North America led the market in 2024, while Asia Pacific is projected to witness the fastest growth ahead.

Product Segment: Reagents & consumables dominated in 2024, whereas equipment is forecasted to grow at the highest CAGR.

Technology Trends: Liquid phase synthesis held the largest share in 2024, but hybrid technology is expected to grow fastest.

End-Use Dynamics: Pharma & biotech companies led in 2024, while CDMOs/CROs are set to expand rapidly during 2025–2034.

[towardshealthcare]

Clear Aligners Market Latest Trends, Size and Growth Factors 2025

The global clear aligners market was valued at USD 6.51 billion in 2024, rising to USD 8.55 billion in 2025 and projected to hit USD 99.44 billion by 2034. With a robust CAGR of 31.34% during 2025–2034, the market is driven by increasing demand for aesthetic dental solutions. North America leads the market, while Asia Pacific is set to witness the fastest growth. Age, material, and distribution channel trends highlight strong opportunities for expansion across different segments.

Key Highlights

USD 99.44 Billion by 2034 – Market to surge from USD 6.51 Bn (2024) to USD 99.44 Bn (2034), showing massive growth.

31.34% CAGR (2025–2034) – Strong growth trajectory driven by rising adoption of clear aligners worldwide.

North America leads, Asia Pacific fastest-growing – North America dominated in 2024, while APAC is projected to expand rapidly.

Adults dominate, teens growing fastest – Adults accounted for the largest share in 2024, while teens segment shows highest CAGR.

Offline dominated, online growing fastest – Offline distribution held the largest share in 2024, but online channels are set to rise sharply.